TRi-1 T5481
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TRi-1 is irreversible inhibitor of�cytosolic thioredoxin reductase 1 (TXNRD1), with an�IC50�of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy
CAS nr:
246020-68-8
Purity:
98%
Molecular Weight:
328,72
SMILES:
COc1ccc(c(n1)S(=O)(=O)c1ccc(Cl)cc1)[N+]([O-])=O
Formula:
C12H9ClN2O5S
Pathway:
Others
Target:
Others
